Records containing: Myelodysplastic Syndromes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-07-01Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation For Patients With Disease Relapse Or Myelodysplasia After Prior Autologous Transplantation
-
CLINICAL_TRIALS study record update · 2016-06-27Non-Myeloablative Conditioning and Unrelated Umbilical Cord Blood Transplantation for Children and Adults With Serious Oncohematologic Diseases
-
CLINICAL_TRIALS study record update · 2016-06-23An Open Label Study of the Effects of a Combination of NeoRecormon, CellCept and Prednisone on Hematological Parameters and Cytogenesis in Patients With Low or Intermediate Risk Myelodysplastic Syndromes.¿
-
CLINICAL_TRIALS study record update · 2016-05-09A Phase II Pilot Study of VELCADE in Patients With MDS
-
CLINICAL_TRIALS study record update · 2016-04-15ClinicalTrials.gov study NCT00000591
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-04-14ClinicalTrials.gov study NCT00000603
-
CLINICAL_TRIALS study record update · 2016-03-16A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Epoetin Alfa Versus Placebo in Anemic Patients With IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2016-03-07A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN #0402)
-
CLINICAL_TRIALS study record update · 2016-03-02Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Thoracic and Myeloid Neoplasms
-
CLINICAL_TRIALS study record update · 2016-02-29A Pilot Study of Double Cord Blood Stem Cell Transplantation in Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2016-02-18Blood and Marrow Transplant Clinical Research Network
-
CLINICAL_TRIALS study record update · 2016-02-17A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2016-02-15Maintenance Therapy With Decitabine After Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2016-02-12Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2016-01-22Phase I/II Trial Of Sequential Therapy With Cytarabine And Bismuth-213-Labeled HuM195 (Humanized Anti-CD33) In Patients With Advanced Myeloid Malignancies
-
CLINICAL_TRIALS study record update · 2016-01-18A Phase II Study to Determine the Safety and Efficacy of INCB024360 in Patients With Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2016-01-15Calcitriol and Dexamethasone for Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2016-01-05Phase II Trial of High Dose Lenalidomide in Patients With Myelodysplastic Syndrome Refractory to Hypomethylating Agents
-
CLINICAL_TRIALS study record update · 2015-12-31HLA-HAPLOIDENTICAL FAMILIAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION AFTER REDUCED INTENSITY CONDITIONING OF BUSULFAN, FLUDARABINE, AND ANTI-THYMOCYTE GLOBULIN FOR PATIENTS WITH BONE MARROW FAILURE SYNDROME - A PHASE 2 STUDY
-
CLINICAL_TRIALS study record update · 2015-12-23A Phase II Trial of T-Cell Depleted Marrow Grafts Combined With Infusions of G-CSF Stimulated, CD34 Ceprate Stem Cell Column Selected, E-Rosette Depleted Peripheral Blood Progenitor Cells Derived From HLA Haplotype Matched Related Donors for Patients With Leukemia Lacking an HLA-Matched Related or Unrelated Donor
-
CLINICAL_TRIALS study record update · 2015-12-22Phase II Trial of T-Cell Depleted Hematopoietic Stem Cell Transplants (SBA-E-BM) From HLA Compatible Related or Unrelated Donors After a Myeloablative Preparative Regimen of Hyperfractionated TBI, Thiotepa and Cyclophosphamide (TBI/Thio/cy) for Treatment of Patients Less Than or Equal to 18 Years With Lymphohematopoietic Disorders
-
CLINICAL_TRIALS study record update · 2015-12-02Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2015-11-10MT2008-15: Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematological Malignancies Using a Nonmyeloablative Preparative Regimen and Priming With Complement 3a Fragment (C3a)
-
CLINICAL_TRIALS study record update · 2015-08-31A PHASE I TRIAL OF ALLOREACTIVE NK CELLS INFUSION FOLLOWING TRANSPLANTATION OF HAPLOTYPE MISMATCHED, KIR MISMATCHED HIGHLY PURIFIED CD34 CELLS IN PATIENTS WITH ADVANCED OR REFRACTORY MYELOID MALIGNANCIES
-
CLINICAL_TRIALS study record update · 2015-08-25A Phase I/II Dose Escalation Study of MK0457 in Patients With Leukemia